Holders over time
- CHE
- ELV
| Quarter | CHE | ELV |
|---|---|---|
| Q3 2020 | 16 holders, $1.0bn | 30 holders, $15.0bn |
| Q4 2020 | 14 holders, $1.1bn | 29 holders, $16.7bn |
| Q1 2021 | 13 holders, $898m | 25 holders, $18.6bn |
| Q2 2021 | 13 holders, $920m | 30 holders, $19.4bn |
| Q3 2021 | 13 holders, $1.0bn | 26 holders, $18.5bn |
| Q4 2021 | 13 holders, $1.1bn | 29 holders, $23.3bn |
| Q1 2022 | 12 holders, $906m | 31 holders, $23.9bn |
| Q2 2022 | 12 holders, $798m | 32 holders, $23.3bn |
| Q3 2022 | 12 holders, $664m | 34 holders, $22.6bn |
| Q4 2022 | 13 holders, $834m | 34 holders, $25.5bn |
| Q1 2023 | 13 holders, $855m | 39 holders, $22.5bn |
| Q2 2023 | 13 holders, $961m | 38 holders, $20.6bn |
| Q3 2023 | 16 holders, $982m | 34 holders, $19.8bn |
| Q4 2023 | 13 holders, $1.1bn | 36 holders, $20.3bn |
| Q1 2024 | 12 holders, $1.1bn | 35 holders, $21.3bn |
| Q2 2024 | 14 holders, $912m | 33 holders, $22.1bn |
| Q3 2024 | 13 holders, $693m | 30 holders, $20.2bn |
| Q4 2024 | 11 holders, $588m | 32 holders, $15.9bn |
| Q1 2025 | 12 holders, $657m | 28 holders, $17.1bn |
| Q2 2025 | 11 holders, $582m | 27 holders, $14.8bn |
| Q3 2025 | 8 holders, $487m | 27 holders, $12.7bn |
| Q4 2025 | 13 holders, $634m | 25 holders, $17.0bn |
| Q1 2026 | 12 holders, $612m | 26 holders, $13.6bn |
| Q2 2026 | 10 holders, $807m | 28 holders, $17.7bn |
Chemed Corp New
- Holders
- 12
- Reported value
- $612m
- Buyers
- 15
- Sellers
- 14
Breadth +1 among 91 comparable managers.
Elevance Health Inc Formerly
- Holders
- 26
- Reported value
- $13.6bn
- Buyers
- 24
- Sellers
- 17
Breadth +7 among 91 comparable managers.
Who holds both, Q1 2026
Only CHE (9)
AQR Capital Management LLC, Caxton Associates LLP, ExodusPoint Capital Management LP, GAMCO Investors Inc, Moore Capital Management LP, Neuberger Berman Group LLC, Quantbot Technologies LP, Two Sigma Investments LP, Voloridge Investment Management LLC
Only ELV (23)
AllianceBernstein LP, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Baupost Group LLC, Brevan Howard Capital Management LP, Capital Research Global Investors, Citadel Advisors LLC, D. E. Shaw & Co., Davidson Kempner Capital Management LP, Dodge & Cox, Fidelity (FMR LLC), First Eagle Investment Management LLC, Freestone Grove Partners LP, Harris Associates LP, Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, MFS Investment Management, Millennium Management LLC, Ruane Cunniff & Goldfarb LP, T. Rowe Price Associates Inc, Wellington Management Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.